| BCBS Premera WA AK Clinical | Pharmacologic Treatment of Epidermolysis Bullosa | 2026-01-01 |
| Medical Mutual | Adstiladrin® (nadofaragene firadenovec-vncg) (Intravesical) (EOV) | 2026-01-01 |
| Medical Mutual | Bavencio® (avelumab) (Intravenous) (EOV) | 2026-01-01 |
| Medical Mutual | Breyanzi® (lisocabtagene maraleucel) (Intravenous) (EOV) | 2026-01-01 |
| Medical Mutual | Imfinzi® (durvalumab) (Intravenous) (EOV) | 2026-01-01 |
| Medical Mutual | Imjudo® (tremelimumab-actl) (Intravenous) (EOV) | 2026-01-01 |
| Medical Mutual | Jemperli (dostarlimab-gxly) (Intravenous) (EOV) | 2026-01-01 |
| Medical Mutual | Loqtorzi® (toripalimab-tpzi) (Intravenous) (EOV) | 2026-01-01 |
| Medical Mutual | Padcev® (enfortumab vedotin-ejfv) (Intravenous) (EOV) | 2026-01-01 |
| Medical Mutual | Polivy® (polatuzumab vedotin-piiq) (Intravenous) (EOV) | 2026-01-01 |